Raritan Recalls Kids' Relief Ear Liquid Due to Manufacturing Deviations
Raritan Pharmaceuticals is recalling 22,704 bottles of Kids' Relief Ear Relief Oral Liquid in New York due to CGMP deviations.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and is voluntary due to CGMP deviations, which aligns with the rubric for moderate severity involving voluntary precautionary recalls or minor labeling/manufacturing errors without reported injuries.
Plain-English summary
Raritan Pharmaceuticals, Inc. is voluntarily recalling 22,704 bottles of Kids' Relief Ear Relief Oral Liquid, 0.85 fl oz. (25 mL). The affected product is identified by Lot # 35254 and an expiration date of 05/20. The recall was initiated on November 18, 2016, and was classified as Class II by the FDA.
The reason for the recall is Current Good Manufacturing Practice (CGMP) deviations. The product was distributed in New York. The recall status is currently terminated as of January 8, 2020.
Consumers who have this product should stop using it and contact the manufacturer or their healthcare provider for further instructions.
The recalled product
- Product
- Kids' Relief Ear Relief Oral Liquid 0.85 fl oz. (25 mL) 3025 de'l Assomption Blvd. Montreal, QC H1N 2H2 Canada NDC 60512-913-8 UPC 77815909639
- Manufacturer
- Raritan Pharmaceuticals, Inc.
- Category
- Drug — Ophthalmic/Ear
- Hazard
- Affected units
- 22,704
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # 35254
- Exp. 05/20
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 3 recalled by Raritan Pharmaceuticals, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same manufacturer · Raritan Pharmaceuticals, Inc.
See all →- ModerateCVS Health Homeopathic Infants Teething Tablets Recalled for CGMP Deviations
FDA (Drugs) · 2017-01-04
- ModerateRaritan Recalls CVS Kids' Ear Relief Liquid for Manufacturing Deviations
FDA (Drugs) · 2017-01-04
- SevereRaritan Recalls Up&Up Psyllium Fiber Supplement for C. Difficile Contamination
FDA (Drugs) · 2012-10-31
- SevereEquate Fiber Therapy Recalled for Possible C. Difficile Contamination
FDA (Drugs) · 2012-10-31
- SevereRaritan Recalls Leader Fiber Capsules Due to C. Difficile Contamination
FDA (Drugs) · 2012-10-31
Same hazard · cgmp deviations
See all →- ModerateFentanyl Citrate Injectable Solution Recall Due to cGMP Deviations
FDA (Drugs) · 2026-05-06
- ModerateGlenmark Pharmaceuticals Recalls Pravastatin Sodium Tablets 80mg
FDA (Drugs) · 2025-04-16
- ModerateGlenmark Lacosamide 100mg Tablets Recalled for CGMP Deviations
FDA (Drugs) · 2025-04-16
- ModerateDrug Recall: APAP 500 mg Phenyl HCl Tablets for CGMP Deviations
FDA (Drugs) · 2022-02-16
- ModerateMigrenol Caplet Drug Recalled for CGMP Deviations
FDA (Drugs) · 2022-02-16